2023
0842 Feasibility of daytime bright light exposure and urinary 6-sulfatoxymelatonin profiling in the medical ICU: A pilot study
Intihar T, Doyle M, Lukas M, Wright K, Redeker N, Pisani M, Yaggi H, Knauert M. 0842 Feasibility of daytime bright light exposure and urinary 6-sulfatoxymelatonin profiling in the medical ICU: A pilot study. Sleep 2023, 46: a371-a371. DOI: 10.1093/sleep/zsad077.0842.Peer-Reviewed Original ResearchMedical intensive care unitMICU patientsDaytime bright light exposureStudy days 1Intensive care unitIllness severity scoresBright light exposureWarrants further investigationCircadian outcomesMedical ICUCritical illnessIll patientsOngoing RCTsCare unitCircadian timingMean ageMelatonin useCircadian phaseSeverity scorePilot trialSufficient urinePatientsStudy daysBright lightDay 1
2022
0583 Tolerance and feasibility of daytime bright light in medical intensive care unit patients
Intihar T, Samojedny V, Korwin A, Knauert M. 0583 Tolerance and feasibility of daytime bright light in medical intensive care unit patients. Sleep 2022, 45: a256-a257. DOI: 10.1093/sleep/zsac079.580.Peer-Reviewed Original ResearchMICU patientsCritical illnessMedical ICUControl trialChronic Health Evaluation II scoreMedical intensive care unit patientsIntensive care unit patientsMean patient ageCare unit patientsSeverity of illnessBright light exposureRandomized control trialOngoing randomized control trialAcute PhysiologyII scoreUsual carePatient ageUnit patientsIll patientsBright-light interventionSixteen patientsPoor outcomeClinical investigationBright lightPatients